Gene: ZFAND3
Official Full Name: zinc finger AN1-type containing 3provided by HGNC
Gene Summary: Predicted to enable DNA binding activity and zinc ion binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12410 | ZFAND3 Knockout cell line (HeLa) | Human | ZFAND3 | 1:3~1:6 | Negative | Online Inquiry |
KO12411 | ZFAND3 Knockout cell line (HCT 116) | Human | ZFAND3 | 1:2~1:4 | Negative | Online Inquiry |
KO12412 | ZFAND3 Knockout cell line (HEK293) | Human | ZFAND3 | 1:3~1:6 | Negative | Online Inquiry |
KO12413 | ZFAND3 Knockout cell line (A549) | Human | ZFAND3 | 1:3~1:4 | Negative | Online Inquiry |
ZFAND3 Gene Knockout Cell Lines are specialized cellular tools that have been genetically modified to disrupt the ZFAND3 gene, which encodes a zinc finger-associated protein involved in critical biological processes, including cellular stress responses and protein degradation pathways. This knockout model provides invaluable insights into the physiological roles of ZFAND3 by enabling researchers to study the functional consequences of gene loss in a controlled environment.
The primary mechanism of action for these knockout cell lines involves the elimination of ZFAND3 protein expression, allowing scientists to investigate changes in cellular signaling pathways, gene expression profiles, and phenotypic variations that arise from this loss. By utilizing CRISPR-Cas9 techniques, these cell lines ensure precise gene editing, leading to reproducible results crucial for downstream applications. The ability to manipulate ZFAND3 expression provides researchers with a robust system for dissecting the gene's involvement in diseases such as cancer and neurodegenerative disorders.
The scientific importance of ZFAND3 Gene Knockout Cell Lines extends to both basic and applied research. They serve as a platform for studying gene function, validating therapeutic targets, and screening small molecules in drug discovery processes. Their relevance in clinical settings is underscored by their potential to help identify new biomarkers and therapeutic strategies for challenging diseases, thereby enhancing translational research efforts.
What sets our ZFAND3 Gene Knockout Cell Lines apart from alternatives is their exceptional quality and validation. Developed through rigorous quality control measures, our cell lines exhibit stable genetic modifications and robust performance across multiple assays. Furthermore, these lines are optimized for various applications, including high-throughput screenings and complex co-culture systems, making them versatile tools for diverse research needs.
For researchers and clinicians seeking reliable models to elucidate the role of ZFAND3 in health and disease, our ZFAND3 Gene Knockout Cell Lines prove invaluable. They provide a reliable, reproducible, and easy-to-use platform for the exploration of gene function, ultimately accelerating the pace of discovery in molecular biology and genomics.
At [Company Name], we pride ourselves on our commitment to quality and innovation in biological products, offering cutting-edge solutions that empower the scientific community to make groundbreaking advancements.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.